Robert A S Ariëns Selected Research

Rupture

12/2011

Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A S Ariëns Research Topics

Disease

33	Thrombosis (Thrombus) 03/2024 - 08/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 08/2004
8	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024 - 10/2002
7	Myocardial Infarction 01/2023 - 07/2003
6	Inflammation (Inflammations) 01/2023 - 08/2004
6	Hemorrhage 08/2017 - 08/2010
5	Vascular Diseases (Vascular Disease) 10/2022 - 09/2002
4	Pulmonary Embolism 01/2023 - 05/2003
4	Stroke (Strokes) 01/2023 - 09/2002
4	Ischemic Stroke 01/2023 - 09/2002
3	COVID-19 09/2023 - 01/2021
3	Thrombophilia 01/2023 - 10/2002
3	Abdominal Aortic Aneurysm 01/2014 - 07/2010
2	Diabetes Mellitus 01/2023 - 11/2014
2	Obesity 01/2023 - 06/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 10/2002
2	Wounds and Injuries (Trauma) 03/2022 - 01/2022
2	Venous Thromboembolism 01/2021 - 12/2011
2	Embolism (Embolus) 01/2021 - 01/2012
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2016 - 11/2014
2	Aneurysm (Aneurysms) 06/2013 - 12/2011
2	Intermittent Claudication 04/2009 - 12/2008
2	Type 2 Diabetes Mellitus (MODY) 08/2004 - 01/2002
1	Acute Lung Injury 09/2023
1	Respiratory Insufficiency (Respiratory Failure) 09/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Sepsis (Septicemia) 01/2023
1	Coronary Disease (Coronary Heart Disease) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Heart Failure 01/2023
1	Thromboinflammation 10/2022
1	Bacterial Infections (Bacterial Infection) 03/2022
1	Infections 03/2022
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2021
1	Thromboembolism 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2021
1	Benign Fibrous Histiocytoma (Dermatofibroma) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hemolysis 01/2020
1	Diabetes Complications 12/2019
1	Non-alcoholic Fatty Liver Disease 06/2016
1	Liver Diseases (Liver Disease) 06/2016
1	Fibrosis (Cirrhosis) 06/2016

Drug/Important Bio-Agent (IBA)

39	FibrinIBA 09/2023 - 01/2002
19	Fibrinogen (Factor I)FDA Link 03/2024 - 05/2003
7	Factor XIII (Coagulation Factor XIII)IBA 01/2020 - 03/2002
6	estropipate (Ogen)FDA LinkGeneric 01/2023 - 05/2010
5	Proteins (Proteins, Gene)FDA Link 07/2021 - 08/2002
5	Factor XIIIaIBA 01/2021 - 08/2002
4	AnticoagulantsIBA 10/2023 - 11/2014
4	fibrin fragment D (D-dimer)IBA 01/2021 - 03/2002
4	Complement System Proteins (Complement)IBA 01/2021 - 01/2018
4	Thrombin FDA Link 06/2016 - 03/2002
4	AntigensIBA 06/2011 - 03/2002
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2023 - 03/2002
3	Peptides (Polypeptides)IBA 01/2021 - 08/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2014
2	Hemostatics (Antihemorrhagics)IBA 01/2023 - 06/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2022 - 01/2002
2	CholesterolIBA 01/2021 - 12/2008
2	LigandsIBA 01/2021 - 01/2019
2	von Willebrand FactorIBA 01/2021 - 01/2021
2	Particulate MatterIBA 07/2016 - 01/2010
2	Prothrombin (Factor II)IBA 06/2013 - 03/2002
1	trichostatin A (A 300)IBA 09/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	Eptifibatide (Integrilin)FDA Link 01/2023
1	ibrutinibIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	2- (2- aminocyclohexylamino)- 4- (m- tolylamino)pyrimidine- 5- carboxamideIBA 01/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2022
1	Bacterial Proteins (Bacterial Protein)IBA 03/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	IntegrinsIBA 01/2021
1	platelet membrane glycoprotein VIIBA 01/2021
1	TroponinIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	factor XIII subunit AIBA 01/2020
1	eculizumab FDA Link 01/2020
1	TransglutaminasesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2017
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2017
1	Alanine (L-Alanine)FDA Link 02/2016
1	Leucine (L-Leucine)FDA Link 02/2016
1	Valine (L-Valine)FDA Link 02/2016
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2016

Therapy/Procedure

5	Therapeutics 03/2022 - 07/2003
2	Thrombectomy 01/2021 - 01/2021
1	Catheters 03/2024
1	Artificial Respiration (Mechanical Ventilation) 09/2023
1	Lasers (Laser) 01/2023
1	Thrombolytic Therapy 01/2021